IGC Pharma, Inc.
IGC
$0.29
$0.000.32%
AMEX
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 48.71% | 52.32% | 45.22% |
| Total Depreciation and Amortization | -- | -- | -9.51% | -7.30% | -2.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -79.00% | -66.36% | -66.22% |
| Change in Net Operating Assets | -- | -- | -140.65% | -128.21% | -103.80% |
| Cash from Operations | -- | -- | -14.05% | 18.84% | 7.77% |
| Capital Expenditure | -- | -- | 45.33% | 47.44% | 18.84% |
| Sale of Property, Plant, and Equipment | -- | -- | 3,805.56% | 74,100.00% | -9.09% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -47.54% | -35.76% | -65.92% |
| Cash from Investing | -- | -- | 93.10% | 160.72% | -39.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | 28.82% | -53.64% | 26.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 28.84% | -53.66% | 26.31% |
| Foreign Exchange rate Adjustments | -- | -- | 633.33% | 420.00% | -16.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 70.20% | -1,456.44% | 60.31% |